Cargando…
Omalizumab: Practical considerations regarding the risk of anaphylaxis
Omalizumab has demonstrated efficacy among patients with moderate to severe persistent allergic asthma, whose symptoms are inadequately controlled with other controller agents. This therapy is generally well tolerated, but there are some safety considerations, the most important of which is the rare...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3006370/ https://www.ncbi.nlm.nih.gov/pubmed/21129189 http://dx.doi.org/10.1186/1710-1492-6-32 |